Low-dose versus standard-dose bacille Calmette–Guérin for non-muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized controlled trials

Low-dose versus standard-dose bacille Calmette–Guérin for non-muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized controlled trials

Purpose: Intravesical BCG (bacille Calmette–Guérin) instillation in patients with non-muscle-invasive bladder cancer decreases the risk for tumor recurrence and progression. After one BCG product was discontinued, a chronic global BCG shortage occurred. We focused on identifying a reduced dose of BC...

Full description

Bibliographic Details
Main Authors: Se Young Choi, Moon Soo Ha, Jung Hoon Kim, Byung Hoon Chi, Jin Wook Kim, In Ho Chang, Tae-Hyoung Kim, Soon Chul Myung
Format: Article
Language:English
Published: Korean Urological Association 2022-03-01
Series:Investigative and Clinical Urology
Subjects:
administration
intravesical
adverse effects
recurrence
urinary bladder neoplasms
Online Access:https://www.icurology.org/pdf/10.4111/icu.20210340

Internet

https://www.icurology.org/pdf/10.4111/icu.20210340

Similar Items